Annetine C Gelijns, PhD, JD
img_Annetine C Gelijns
PROFESSOR AND SYSTEM CHAIR | Population Health Science and Policy

LLM, Universities of Leyden Law School and Utrecht Department of Health Administration, School of Medicine

PhD, University of Amsterdam School of Medicine and Department of Science Policy

1994

Investigator Award in Health Policy Research

Robert Wood Johnson Foundation, Princeton, NJ

1987

International Fellow, Council on Health Care Technology

Institute of Medicine, National Academy of Sciences, Washington, DC

1987

The Querido-Award for the most promising young investigator in public health, the National Foundation for Health Promotion and Disease Prevention (Praeventiefonds)

The Hague, the Netherlands

Publications

Selected Publications

Clinical practice patterns among older multimorbid adults presenting with suspected ischemic symptoms: A multi-center survey. Stephanie Jou, Laura P. Gelfman, Karen P. Alexander, R. Sean Morrison, Deepak L. Bhatt, Alan Moskowitz, Emilia Bagiella, Annetine Gelijns, Gregg W. Stone, David J. Cohen, Leslee J. Shaw, Krishna K. Patel. American Heart Journal Plus: Cardiology Research and Practice

SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial). Sofía Sábato, Susana Benet, Angela J. Rogers, Thomas A. Murray, Melissa Skeans, Beatriz Mothe, Roger Paredes, Ahmad Mourad, Francis Kiweewa, Dena Kamel, Mamta K. Jain, Joseph Lutaakome, Mary Grace Nalubega, Nicholus Sebudde, Eleftherios Mylonakis, Dominique L. Braun, Timothy Hatlen, Ivan Kimuli, Cissy Kitko, Henry Mugerwa, Jonathan Kitonsa, Kami Kim, Phyllis C. Tien, Jeroen Highbarger, Ashley L. McCormack, Adriana Sanchez, Daniel D. Murray, Abdel G. Babiker, Victoria J. Davey, D. Clark Files, Annetine C. Gelijns, Elizabeth S. Higgs, Virginia L. Kan, Gail V. Matthews, Sarah L. Pett, H. Clifford Lane, Cavan Reilly, Anna L. Goodman, Jens D. Lundgren, José Moltó. Scientific Reports

Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. Cavan Reilly, Eleftherios Mylonakis, Robin Dewar, Barnaby Young, Jacqueline Nordwall, Sanjay Bhagani, Po Ying Chia, Ruby Davis, Clark Files, Adit A. Ginde, Timothy Hatlen, Marie Helleberg, Awori Hayanga, Tomas O. Jensen, Mamta K. Jain, Ioannis Kalomenidis, Kami Kim, Perrine Lallemand, Birgitte Lindegaard, Anupama Menon, Katherine Ognenovska, Garyfallia Poulakou, Birgit Thorup Røge, Angela J. Rogers, Katy Shaw-Saliba, Uriel Sandkovsky, Barbara W. Trautner, Shikha S. Vasudeva, Andrew Vekstein, Kimberley Viens, James Wyncoll, Brian DuChateau, Zhenxing Zhang, Shujiang Wu, Abdel G. Babiker, Victoria Davey, Annetine Gelijns, Elizabeth Higgs, Virginia Kan, Jens Lundgren, Gail V. Matthews, H. Cliff Lane. Journal of Infectious Diseases

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Gelijns has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.